Thomas David Hull III Sells 3,000 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III sold 3,000 shares of the business’s stock in a transaction on Monday, March 24th. The shares were sold at an average price of $45.63, for a total value of $136,890.00. Following the completion of the sale, the chief executive officer now directly owns 37,916 shares in the company, valued at approximately $1,730,107.08. This represents a 7.33 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Thomas David Hull III also recently made the following trade(s):

• On Friday, March 21st, Thomas David Hull III sold 213 shares of Kewaunee Scientific stock. The shares were sold at an average price of $48.53, for a total transaction of $10,336.89.
• On Friday, January 10th, Thomas David Hull III sold 1,368 shares of Kewaunee Scientific stock. The shares were sold at an average price of $60.08, for a total transaction of $82,189.44.
• On Thursday, December 26th, Thomas David Hull III sold 2,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $63.01, for a total transaction of $126,020.00.

Kewaunee Scientific Trading Down 3.3 %

Shares of Kewaunee Scientific stock traded down $1.54 on Monday, hitting $44.96. The stock had a trading volume of 43,557 shares, compared to its average volume of 22,493. The firm has a market capitalization of $128.36 million, a P/E ratio of 7.13 and a beta of 0.71. Kewaunee Scientific Co. has a twelve month low of $30.82 and a twelve month high of $71.33. The stock has a 50 day moving average of $57.46 and a 200 day moving average of $47.68. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. The firm had revenue of $67.17 million for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Institutional Investors Weigh In On Kewaunee Scientific

A number of hedge funds have recently modified their holdings of the stock. Invesco Ltd. bought a new stake in Kewaunee Scientific during the 4th quarter valued at $6,545,000. Marshall Wace LLP purchased a new stake in Kewaunee Scientific during the 4th quarter worth about $736,000. De Lisle Partners LLP lifted its holdings in Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after purchasing an additional 11,511 shares in the last quarter. Truffle Hound Capital LLC bought a new position in Kewaunee Scientific in the 4th quarter worth about $619,000. Finally, State Street Corp purchased a new position in Kewaunee Scientific during the 3rd quarter valued at about $266,000. Institutional investors own 32.69% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of Kewaunee Scientific from a “buy” rating to a “hold” rating in a research note on Friday, March 14th.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.